Emory professor Max Cooper’s historic discoveries forever changed our understanding of the adaptive immune system, fueling lifesaving advances in basic research and medicine. The annual award in his honor is open to national and international candidates across the spectrum of immunology.
Emory Vaccine Center researchers have identified a potential Achilles heel within SARS-CoV-2. The vulnerable spot can be targeted with a peptide derived from wild boar, which maintains its antiviral activity across known variants.
Emory University researcher and inventor Dennis Liotta, PhD, has been named to the Bayh-Dole Coalition’s inaugural “Faces of American Innovation" for helping to transform HIV from a death sentence into a manageable illness.
Emory biologists solve a mystery about how a common insect acquires a microbe that is essential for its growth. The discovery may help in the control of an agricultural pest.
Emory researchers are characterizing a class of enzymes that can confer antibiotic resistance to a range of deadly pathogens. Advanced microscopy techniques yielded the first images of the enzymes in action, offering new clues for how to combat their effects.
The results of a novel study presented by Emory researchers during the International AIDS Society Conference in Brisbane, Australia, have revealed exciting findings in the pursuit of an HIV cure.
The Cancer Research Institute has awarded a five-year STAR program grant of $1.25 million to Haydn T. Kissick, PhD, assistant professor in the Emory School of Medicine and Cancer Immunology researcher at Emory’s Winship Cancer Institute, to search for answers to the difficult question of how T cells can help protect the body against cancer.
New research from Emory University and Marcus Autism Center can potentially identify early brain and behavioral markers associated with social disability, which can inform early-intervention approaches to better support child and family outcomes.
Winship has received renewal of the prestigious Comprehensive Cancer Center designation from the National Cancer Institute, ensuring its continuing place in the top tier of cancer centers in the United States.
The 2023 Albert E. Levy Award for Excellence in Scientific Research went to Jennifer Strafford Stevens and Guido Silvestri in recognition of their groundbreaking research and advancement of scientific knowledge.
Elaine Walker, Charles Howard Candler Professor of Psychology and Neuroscience, is this year’s recipient of the Cuttino Award, recognizing a legacy of support and academic excellence that reverberates across the fields of psychology and mental illness research.
U.S. News and World Report ranks the Woodruff School of Nursing master’s program 1st in the nation and the Rollins School of Public Health 4th.
A new housing option for Emory graduate and professional students is on track to open in fall 2024. The new building will feature 535 beds, plus spaces where residents can build community.
A dozen high school students spent five weeks of their summer shadowing Emory researchers and genetic counselors, getting hands-on experience related to areas of personal interest.
The latest initiative from Human Health, which integrates Emory College’s liberal arts excellence with the university’s renowned health sciences, exposes undergrads to the science, policy, ethics and law behind vaccines and drug discovery.
Learn about nine student projects supported by The Hatchery, Center for Innovation, including closing the diversity gap in cancer research and using Shakespeare to help kids explore emotions.
Researcher and inventor Dennis Liotta is the 2022 recipient of the Perkin Medal, the highest honor a scientist can receive for contributions to applied chemistry in the U.S. His discoveries include transformative treatments for HIV and hepatitis B.
A recent event celebrated faculty who had earned promotion and/or the grant of tenure, were appointed to named and endowed professorships or had earned membership in the National Academies or the American Academy of Arts and Sciences.
In the SAVE program, researchers assess whether mutations in emerging SARS-CoV-2 variants such as Delta and Omicron affect virus transmission, severity and immunity, which in turn supports the testing of vaccines and therapeutics and guides public health responses.
Longstanding partnerships within Georgia and nationwide support Emory’s research and advocacy addressing rare diseases. Learn more during an event in conjunction with Rare Disease Day.
An antibiotic sprayed on orchard crops to combat bacterial diseases slows the cognition of bumblebees and reduces their foraging efficiency, a laboratory study finds. Proceedings of the Royal Society B published the findings by scientists at Emory University and the University of Washington.
Emory University continues to be among the top-ranked institutions for research funding from the National Institutes of Health. In 2021, Emory received $479.5 million and held steady in its overall ranking of 18th in the nation.
As in humans, spontaneous social behaviors of free-ranging juvenile rhesus macaques display significant genetic influences, or heritability. This exploratory study opens new avenues for research on the genetics of autism-related behavior.
Anice Lowen and Katia Koelle are quoted.
Hanjoong Jo, distinguished faculty chair in the Wallace H. Coulter Department of Biomedical Engineering, has been elected as an AAAS Fellow, one of the highest distinctions in the scientific community, for his contributions to atherosclerosis research.
Research from a study by Emory University-Georgia Tech on PTSD using transcutaneous vagus nerve stimulation has led to a Breakthrough Device Designation from the FDA for the gammaCore nVNS device.
Dennis Liotta îs quoted.
Bacteria inside our guts are fine-tuning our metabolism. Emory researchers have identified an obesity-promoting chemical produced by intestinal bacteria.
Boosting levels of norepinephrine may be able to stall neurodegeneration in people with early signs of Alzheimer’s disease, a study conducted at Emory Brain Health Center suggests.
On Dec. 23, molnupiravir, an investigational oral antiviral drug invented by scientists at Emory University, received Emergency Use Authorization from the FDA for the treatment of COVID-19.
An Emory symposium highlighted the ways graduate students have been studying COVID-19 in the hospital and laboratory and modeling disease spread, along with staffing testing events, advising local communities and providing community service and education.
The Goizueta Foundation has committed $50 million to Emory University to establish the Goizueta Institute @Emory Brain Health, renaming the landmark initiative announced in May 2021 as the Emory Brain Health Personalized Medicine Institute.
Research published by Emory anthropologists scanning grandmothers’ brains while they’re viewing photos of their young grandchildren provides a neural snapshot of the special, intergenerational bond.
Juan Rodriguez, a PhD student in the James T. Laney School of Graduate Studies studying Genetics and Molecular Biology, has won the Kharen Fulton Diversity Graduate Award for 2021.
An analysis of published studies from a range of biological specialties shows that, when data are reported by sex, critical statistical analyses are often missing and the findings are likely to be reported in misleading ways. Emory neuroscientist Donna Maney is senior author on the study.
Research is an integral part of Emory, from the sciences to the humanities. Read a sample of recent grant awards across campus along with newly published research findings.
The National Organization for Rare Disorders has named Emory’s Division of Medical Genetics in the Department of Human Genetics, in partnership with the Emory Clinic and Children’s Healthcare of Atlanta, as a NORD Rare Disease Center of Excellence.
Emory researchers received a three-year, $6.3 million grant from the Aligning Science Across Parkinson’s Collaborative Research Network for research into the motor cortical disturbances caused by Parkinson’s disease, which affects more than 6 million people worldwide.
The Medicines Patent Pool and Merck have entered into a licensing agreement to facilitate affordable access for molnupiravir, an investigational oral antiviral COVID-19 medicine, in 105 low- and middle-income countries.
Researchers from Emory School of Medicine have outlined the impact of inflammation on motivation, as it relates to depression, in a paper published recently in Pharmacological Reviews.
Emory ethnobotanist Cassandra Quave publishes a memoir celebrating a life in science, from her roots to the fruits of her labor. A campus Q&A with the author will be held Tuesday, Oct. 26.
With Merck’s findings that Emory-discovered molnupiravir may significantly reduce the risk of hospitalization or death from COVID-19, Emory President Gregory L. Fenves joins epidemiologist Jodie Guest in a conversation about Emory’s history of research innovation.
Emory faculty and staff are frequently recognized for their work locally, nationally and internationally. Read a sampling of recent accolades, including awards for professional contributions and leadership appointments.
Ilya Nemenman was instrumental in Emory becoming a global leader in theoretical and modeling approaches to living systems. Now he has received one of the most prestigious recognitions for theoretical scientists in the prime of their research careers.
Larry Young is quoted.
Honored for outstanding mentorship, Emory biologist Samuel Sober says his research into how the brain controls muscle movement has long been a collaborative effort.
The National Institutes of Health has announced a New Innovator Award for Emory researcher Candace Fleischer, who plans to use magnetic resonance imaging in new ways to study metabolic disease.
Emory researcher Chethan Pandarinath is using artificial intelligence to build brain-machine interfaces to assist people with paralysis, specifically those with Amyotrophic Lateral Sclerosis. The NIH award will support a clinical trial launching this fall.
More than 1,500 in-person runners and hundreds more virtually participated in the Winship Win the Fight 5K Run/Walk's first ever hybrid event and helped raise over $800,000 for cancer research.
Though their main campuses are located less than six miles apart, Emory University and Georgia Tech have combined forces and complementary strengths to make Atlanta — and the world — a better place.
Emory University ranked 20th out of 796 U.S. universities according to the 2022 Wall Street Journal/Times Higher Education College Rankings, published Sept. 21.
Research is an integral part of Emory, from the sciences to the humanities. Read a sample of recent grant awards across campus along with newly published research findings.
The Lupus Research Alliance has awarded one of its largest grants to date to a team led by Emory immunologist Ignacio Sanz, MD. The $3 million project will focus on immune cells that produce autoantibodies, specifically in African American patients.
An Emory University-led research collaboration has been awarded a five-year, $23.8 million grant from the National Institutes of Health to fast-track research to cure HIV infection or put it in permanent remission.
Emory faculty and staff are frequently recognized for their work locally, nationally and internationally. Read a sampling of recent accolades, including awards for professional contributions and leadership appointments.
The immune cells that are the major targets of immune checkpoint inhibitors are present in HPV+ tumors from head and neck cancer patients, a Winship/Emory Vaccine Center study reports.
Emory scientists tap big data to target a tiny predator and the viral diseases it spreads, including dengue fever and Zika.
Emory and Georgia Tech investigators recently reported the results of the first human feasibility study of the "Flicker" treatment, a non-pharmaceutical approach designed to slow Alzheimer's disease.
Gonzalo Vazquez-Prokopec quoted.
The Emory community is mourning the passing of Stephen T. Warren, the founding and former chair of the School of Medicine's Department of Human Genetics, who passed away June 6.
Led by neurologist Allan Levey, the Brain Health Personalized Medicine Institute will house a vibrant research program to collect, integrate and analyze large data sets to inform understanding of the biological, medical and lifestyle factors impacting brain health and disease.
The next pandemic could be averted if we better understand why viruses spill over from wildlife to humans. Emory researcher and PhD candidate Amanda Vicente-Santos is looking at bats for answers.
Emory University has been named among the best American universities in the second annual QS USA University Rankings, designed to assess how well universities are responding to current social, intellectual and economic challenges.
New research led by Emory disease ecologist Thomas Gillespie shows that nearly half of the fecal samples from endangered wild chimpanzees contain bacteria that is resistant to a major class of antibiotics commonly used by people in the vicinity of the park.
NIAID has awarded Emory researchers a five-year, $11 million dollar grant to study heteroresistance, a stealthy form of antibiotic resistance that undermines the treatment of bacterial infections.
Emory University’s graduate and professional schools and programs are ranked among the best in the nation, according to U.S. News & World Report’s 2022 edition of the “America’s Best Graduate Schools” guide.
A more contagious coronavirus variant known as B.1.1.7 is still susceptible to antibodies induced after COVID-19 infection or vaccination. But another called B.1.351 modestly reduces antibodies' potency.
Emory University researchers, in an international collaboration with the Trisomy 21 Research Society (T21RS), have found increased COVID-19 mortality among those with Down syndrome compared to the general population.
Emory College physicist Daniel Weissman, who specializes in building mathematical models to better understand the rapid evolution of pathogens, has been named a Sloan Research Fellow. The prestigious fellowship honors the most promising researchers working today.
Researchers at Yerkes National Primate Research Center and Emory Vaccine Center have developed a COVID-19 vaccine that has proven safe and effective in mice and monkeys.
Emory University’s infectious diseases program ranks 5th in the U.S. and 9th in the world, according to U.S. News & World Report. From HIV to Ebola to COVID-19, Emory has led the way in tackling deadly diseases.
Two longtime Emory University academic and research leaders, David Stephens and Lanny Liebeskind, have been named 2020 fellows of the National Academy of Inventors, the highest professional distinction accorded to academic inventors.
Scientists have compiled the first comprehensive review of plant natural products that play a role in antibacterial activity, to serve as a guide in the search for new drugs to combat antibiotic-resistant pathogens.
The National Cancer Institute has awarded a five-year, $9.9 million grant to Emory investigators to study COVID-19 immune responses in patients with cancer or autoimmune diseases.
Supported by a $8 million, five-year grant, an Emory-led team of scientists plans to investigate new therapeutic approaches to fragile X syndrome, the most common inherited intellectual disability and a major single-gene cause of autism.